GLAXOSMITHKLINE (GSK) has
confirmed it will close its Medicines
Research Unit at the Prince of
Wales Hospital in Sydney, which will
see eight full time and five contract
staff lose their jobs.
The unit would close on 30 Sep,
GSK said.
It said changes to the global
R&D landscape and so its business
model had meant the volume
of studies and type of work
channelled through the facility had
changed.
However it would continue to
conduct “globally sponsored”
clinical trials (phase one to four) in
Australia and New Zealand from its
Melbourne office, it said.
GSK Australia pharmaceuticals gm
Geoffrey McDonald said sustainable
R&D meant the company needed to
continually monitor and maximise
its return on investment.
CLICK HERE for more.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Aug 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Aug 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.